The World Health
Organization (WHO) has
reported that the drug
used to fight breast cancer all over the world can
actually be a carcinogenic agent by increasing the risk of
contracting endometrial cancer. The disturbing news about Tamoxifen, the medicine given to women after breast cancer
operations, was the result of a study
consisting of 17 scientists from different
countries at the WHO's International
Agency for Research of Cancer (IARC) in
However, Nick Gaudin, spokesperson for IARC says the benefits of Tamoxifen far outweigh its potential risks and women being treated for breast cancer should not stop their treatment.
In spite of criticisms directed against it, the UN is all set to fund the second world conference on human settlements to be held from June 3-14 in Istanbul, Turkey. Considering the state of bankruptcy hat the UN finds itself in, countries like the US have voiced their concern on the UN move. Dismissing them, however, UN officials are at pains to insist that the conference would promote the habitat housing activities worldwide. The UN has sponsored six international conferences so far in six years.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.